• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃切除术对胃癌患者炎症性肠病风险的影响:批判性分析。

The Impact of Gastrectomy on Inflammatory Bowel Disease Risk in Gastric Cancer Patients: A Critical Analysis.

机构信息

Department of General Surgery, University Hospital of Larissa, University of Thessaly, Biopolis Campus, 41110 Larissa, Greece.

Department of Emergency Medicine, General Hospital of Larissa, 41221 Larissa, Greece.

出版信息

Curr Oncol. 2024 Sep 25;31(10):5789-5801. doi: 10.3390/curroncol31100430.

DOI:10.3390/curroncol31100430
PMID:39451734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11506527/
Abstract

Gastrectomy, a prevalent surgical procedure for gastric cancer, results in substantial alterations to the gastrointestinal tract, including reduced gastric acid production and significant modifications to the gut microbiota. These changes can impair postoperative recovery, influence metabolic functions, and predispose patients to inflammatory bowel disease (IBD). Studies have shown an increased risk of IBD, particularly Crohn's disease (CD) and ulcerative colitis (UC), in patients following gastrectomy and bariatric surgeries such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). For instance, patients undergoing RYGB have a higher hazard ratio for developing CD, while SG patients show an increased risk for UC. The surgical alteration of the gastrointestinal tract promotes dysbiosis, with a significant increase in pathogenic bacteria and a decrease in beneficial microbial populations. This dysbiosis can impair the intestinal mucosal barrier and promote systemic inflammation. Understanding the mechanisms behind these changes and their clinical implications is essential for developing effective postoperative management strategies. Probiotics and enhanced recovery after surgery (ERAS) protocols have shown promise in mitigating these adverse effects, improving gut microbiota balance, and enhancing patient outcomes. Further research is necessary to fully elucidate the long-term impacts of gastrectomy on gastrointestinal health and to refine therapeutic approaches for postoperative care.

摘要

胃切除术是治疗胃癌的常见手术方法,会导致胃肠道发生重大改变,包括胃酸生成减少和肠道微生物群的显著改变。这些变化会影响术后恢复、代谢功能,并使患者易患炎症性肠病(IBD)。研究表明,胃切除术和减重手术(如 Roux-en-Y 胃旁路术(RYGB)和袖状胃切除术(SG))后患者发生 IBD(尤其是克罗恩病(CD)和溃疡性结肠炎(UC))的风险增加。例如,RYGB 术后患者 CD 的发生风险比更高,而 SG 患者 UC 的风险增加。胃肠道的手术改变会促进肠道菌群失调,导致致病菌显著增加,有益微生物群减少。这种菌群失调会损害肠道黏膜屏障并促进全身炎症。了解这些变化背后的机制及其临床意义对于制定有效的术后管理策略至关重要。益生菌和术后加速康复(ERAS)方案已显示出在减轻这些不利影响、改善肠道微生物群平衡和改善患者预后方面的潜力。需要进一步的研究来充分阐明胃切除术对胃肠道健康的长期影响,并改进术后护理的治疗方法。

相似文献

1
The Impact of Gastrectomy on Inflammatory Bowel Disease Risk in Gastric Cancer Patients: A Critical Analysis.胃切除术对胃癌患者炎症性肠病风险的影响:批判性分析。
Curr Oncol. 2024 Sep 25;31(10):5789-5801. doi: 10.3390/curroncol31100430.
2
Bariatric surgery in morbidly obese patients with inflammatory bowel disease: A systematic review.肥胖症患者合并炎症性肠病的减重手术:一项系统评价。
Surg Obes Relat Dis. 2017 Apr;13(4):652-659. doi: 10.1016/j.soard.2016.10.017. Epub 2016 Oct 25.
3
Uncut Roux-en-Y reconstruction after distal gastrectomy for gastric cancer.远端胃癌切除术后未切割 Roux-en-Y 重建。
Cochrane Database Syst Rev. 2024 Feb 29;2(2):CD015014. doi: 10.1002/14651858.CD015014.pub2.
4
Small Bowel Perforation in Roux-en-Y Gastric Bypass (RYGB) Secondary to Apolipoprotein A-IV (AApoA-IV) Type Amyloidosis.载脂蛋白A-IV(AApoA-IV)型淀粉样变性继发于Roux-en-Y胃旁路术(RYGB)的小肠穿孔
Obes Surg. 2025 May;35(5):1679-1684. doi: 10.1007/s11695-025-07814-8. Epub 2025 Mar 29.
5
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
6
Prepregnancy Roux-en-Y gastric bypass vs sleeve gastrectomy: a systematic review, pairwise, and network meta-analysis of obstetrical and neonatal outcomes.孕前 Roux-en-Y 胃旁路术与袖状胃切除术:产科和新生儿结局的系统评价、成对比较和网络荟萃分析。
Am J Obstet Gynecol MFM. 2023 Jun;5(6):100914. doi: 10.1016/j.ajogmf.2023.100914. Epub 2023 Mar 7.
7
Impact of bariatric surgery on gut microbiota in obese patients: A systematic review.减肥手术对肥胖患者肠道微生物群的影响:一项系统综述。
Indian J Gastroenterol. 2025 Apr 12. doi: 10.1007/s12664-025-01763-x.
8
Surgery for weight loss in adults.成人减肥手术。
Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.
9
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
10
Oral-gut microbiome axis in a Korean cohort with inflammatory bowel disease and ankylosing spondylitis (INTEGRATE): a prospective and observational study protocol.韩国炎症性肠病和强直性脊柱炎队列中的口腔-肠道微生物群轴(INTEGRATE):一项前瞻性观察性研究方案
BMJ Open. 2025 Aug 10;15(8):e092075. doi: 10.1136/bmjopen-2024-092075.

引用本文的文献

1
Comparative Changes in Fecal Microbiome After Endoscopic Resection and Surgical Resection in Gastric Cancer Patients.胃癌患者内镜切除与手术切除后粪便微生物群的比较变化
J Pers Med. 2025 Apr 4;15(4):144. doi: 10.3390/jpm15040144.

本文引用的文献

1
MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease.微小 RNA 特征在炎症性肠病发病机制和治疗中的作用。
Clin Exp Med. 2024 Sep 11;24(1):217. doi: 10.1007/s10238-024-01476-z.
2
The role of microRNAs in the gastric cancer tumor microenvironment.微小 RNA 在胃癌肿瘤微环境中的作用。
Mol Cancer. 2024 Aug 20;23(1):170. doi: 10.1186/s12943-024-02084-x.
3
Enteral Nutrition in Operated-On Gastric Cancer Patients: An Update.术后胃癌患者的肠内营养:最新进展。
Nutrients. 2024 May 27;16(11):1639. doi: 10.3390/nu16111639.
4
Unveiling the Gastrointestinal Microbiome Symphony: Insights Into Post-Gastric Cancer Treatment Microbial Patterns and Potential Therapeutic Avenues.揭开胃肠道微生物组的奥秘:对胃癌治疗后微生物模式及潜在治疗途径的见解
J Gastric Cancer. 2024 Jan;24(1):89-98. doi: 10.5230/jgc.2024.24.e4.
5
Exploring the relationship between and in inflammatory bowel disease (IBD): Insights and implications.探索炎症性肠病(IBD)中[具体内容缺失]与[具体内容缺失]之间的关系:见解与启示。
Comput Struct Biotechnol J. 2023 Nov 19;23:1-9. doi: 10.1016/j.csbj.2023.11.027. eCollection 2024 Dec.
6
Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009-2020.减重手术与炎症性肠病:2009-2020 年美国住院患者中与程序袖状胃切除术相关的国家趋势和结局与历史减重手术比较。
Obes Surg. 2023 Nov;33(11):3472-3486. doi: 10.1007/s11695-023-06833-7. Epub 2023 Oct 7.
7
Changes in salivary microbiota due to gastric cancer resection and its relation to gastric fluid microbiota.胃癌切除术后唾液微生物群的变化及其与胃液微生物群的关系。
Sci Rep. 2023 Sep 22;13(1):15863. doi: 10.1038/s41598-023-43108-8.
8
Inflammation and malnutrition in inflammatory bowel disease.炎症性肠病中的炎症和营养不良。
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):579-590. doi: 10.1016/S2468-1253(23)00011-0. Epub 2023 Mar 15.
9
Association between Fecal Microbiota, SCFA, Gut Integrity Markers and Depressive Symptoms in Patients Treated in the Past with Bariatric Surgery-The Cross-Sectional Study.粪菌移植治疗溃疡性结肠炎的研究进展
Nutrients. 2022 Dec 17;14(24):5372. doi: 10.3390/nu14245372.
10
THE INTESTINAL MICROBIOME IN PATIENTS UNDERGOING BARIATRIC SURGERY: A SYSTEMATIC REVIEW.行减肥手术患者的肠道微生物组:系统评价。
Arq Bras Cir Dig. 2022 Dec 19;35:e1707. doi: 10.1590/0102-672020220002e1707. eCollection 2022.